CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL)

776 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q1 2022.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 631 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 47,548,656 shares of 50,495,188 outstanding shares and own 94% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5,935,727 shares), BlackRock Inc. (5,230,033 shares), FMR LLC (2,388,818 shares), STATE STREET CORP (2,023,477 shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (1,638,683 shares), Clearbridge Investments, LLC (1,368,943 shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (1,142,222 shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1,035,968 shares), GEODE CAPITAL MANAGEMENT, LLC (958,624 shares), and Invesco Ltd. (951,089 shares).
This table shows the top 631 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.